Island Pharmaceuticals Limited (ASX:ILA)
Australia
· Delayed Price · Currency is AUD 0.450
+0.025 (5.88%)
Mar 10, 2026, 10:06 AM AEST
Island Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Cash & Equivalents | 6.87 | 7.25 | 1.66 | 2 | 4.79 | 6.46 | Upgrade
|
| Cash & Short-Term Investments | 6.87 | 7.25 | 1.66 | 2 | 4.79 | 6.46 | Upgrade
|
| Cash Growth | 72.07% | 336.76% | -16.91% | -58.26% | -25.90% | 646064300.00% | Upgrade
|
| Other Receivables | - | 0.18 | 0.89 | 0.02 | 0.02 | 0.06 | Upgrade
|
| Receivables | 0.19 | 0.18 | 0.89 | 0.02 | 0.02 | 0.06 | Upgrade
|
| Prepaid Expenses | 0.17 | 0.06 | 0.01 | 0.03 | 0.09 | 0.12 | Upgrade
|
| Total Current Assets | 7.23 | 7.49 | 2.56 | 2.05 | 4.9 | 6.64 | Upgrade
|
| Total Assets | 8.02 | 7.49 | 2.56 | 2.05 | 4.9 | 6.64 | Upgrade
|
| Accounts Payable | 0.21 | 0.15 | 0.31 | 0.11 | 0.24 | 0.08 | Upgrade
|
| Accrued Expenses | 0.65 | 0.18 | 0.3 | 0.15 | 0.34 | 0.14 | Upgrade
|
| Short-Term Debt | - | - | 0.42 | - | - | - | Upgrade
|
| Other Current Liabilities | 0 | 0 | 0.01 | 0 | 0 | 0.01 | Upgrade
|
| Total Current Liabilities | 0.86 | 0.34 | 1.05 | 0.26 | 0.58 | 0.24 | Upgrade
|
| Total Liabilities | 0.86 | 0.34 | 1.05 | 0.26 | 0.58 | 0.24 | Upgrade
|
| Common Stock | 34.12 | 31.63 | 22.39 | 19.9 | 19.9 | 19.83 | Upgrade
|
| Retained Earnings | -29.9 | -25.08 | -21.2 | -19.76 | -4.73 | -2.13 | Upgrade
|
| Comprehensive Income & Other | 2.94 | 0.61 | 0.33 | 1.65 | -10.85 | -11.3 | Upgrade
|
| Shareholders' Equity | 7.16 | 7.16 | 1.52 | 1.79 | 4.32 | 6.4 | Upgrade
|
| Total Liabilities & Equity | 8.02 | 7.49 | 2.56 | 2.05 | 4.9 | 6.64 | Upgrade
|
| Total Debt | - | - | 0.42 | - | - | - | Upgrade
|
| Net Cash (Debt) | 6.87 | 7.25 | 1.24 | 2 | 4.79 | 6.46 | Upgrade
|
| Net Cash Growth | 72.07% | 485.58% | -38.03% | -58.26% | -25.90% | 646064300.00% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.04 | 0.01 | 0.02 | 0.06 | 0.35 | Upgrade
|
| Filing Date Shares Outstanding | 269.05 | 247.24 | 126.77 | 81.27 | 81.27 | 80.97 | Upgrade
|
| Total Common Shares Outstanding | 269.05 | 236.09 | 126.77 | 81.27 | 81.27 | 80.97 | Upgrade
|
| Working Capital | 6.37 | 7.16 | 1.52 | 1.79 | 4.32 | 6.4 | Upgrade
|
| Book Value Per Share | 0.03 | 0.03 | 0.01 | 0.02 | 0.05 | 0.08 | Upgrade
|
| Tangible Book Value | 6.37 | 7.16 | 1.52 | 1.79 | 4.32 | 6.4 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | 0.03 | 0.01 | 0.02 | 0.05 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.